Thermo Fisher Scientific will pay $450 million in cash for Mesa Biotech, which launched one of the first rapid Covid-19 tests in the early days of the pandemic.
The owner of the 83-story Aon Center is investing $6.5 million to demolish and redesign its half-acre plaza in anticipation of greater demand for outdoor space in a post-pandemic downtown Chicago.
